We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current KNSA market cap is 1.44B. The company's latest EPS is USD 0.1951 and P/E is 101.95.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 67.05M | 83.4M | 79.86M | 108.63M | 112.21M |
| Operating Income | -33.2M | 81k | -16.54M | -117k | -60.47M |
| Net Income | -13.86M | 25.24M | -17.7M | -3.91M | -12.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 38.54M | 220.18M | 270.26M |
| Operating Income | -169.96M | -157.36M | -156.64M | 9.77M | -25.2M |
| Net Income | -161.87M | -161.38M | -157.92M | 183.36M | 14.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 483.06M | 526.32M | 519.67M | 542.43M | 555.3M |
| Total Liabilities | 77.94M | 87.48M | 87.78M | 107.33M | 118.29M |
| Total Equity | 405.13M | 438.84M | 431.9M | 435.1M | 437.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 254.53M | 349.46M | 232.8M | 459.67M | 526.32M |
| Total Liabilities | 29.11M | 37.53M | 47.76M | 63.52M | 87.48M |
| Total Equity | 225.42M | 311.94M | 185.04M | 396.15M | 438.84M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 8.98M | 13.3M | 3.99M | 9.16M | 6.92M |
| Investing | -14.66M | -29.56M | 25.52M | -21.27M | -27.62M |
| Financing | 800k | 1.5M | 3.61M | 3.44M | 10.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -158.37M | -136.53M | -126.3M | 5.81M | 13.3M |
| Investing | 49.21M | -23.44M | 128.64M | -8.08M | -29.56M |
| Financing | 84.11M | 227.09M | 5.89M | 2.52M | 1.5M |
| Market Cap | 1.44B |
| Price to Earnings Ratio | 101.95 |
| Price to Sales Ratio | 5.31 |
| Price to Cash Ratio | 13.3 |
| Price to Book Ratio | 3.27 |
| Dividend Yield | - |
| Shares Outstanding | 72.2M |
| Average Volume (1 week) | 772.37k |
| Average Volume (1 Month) | 579.47k |
| 52 Week Change | 8.10% |
| 52 Week High | 28.15 |
| 52 Week Low | 16.56 |
| Spread (Intraday) | 1.64 (8.11%) |
| Company Name | Kiniksa Pharmaceuticals International PLC |
| Address |
third floor london W1S 4PZ |
| Website | https://www.kiniksa.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
